IP Library Granted Patent US 7,803,551
Granted Patent B2
US 7,803,551 · App. 12/500,860 · Granted Sep 28, 2010

AMPLICON melting analysis with saturation dyes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,803,551
App. No.
12/500,860
Granted
Sep 28, 2010
Kind
B2
Abstract

Methods are provided for nucleic acid analysis wherein a target nucleic acid that is at least partially double stranded is mixed with a dsDNA binding dye having a percent saturation of at least 50% to form a mixture. In one embodiment, the nucleic acid is amplified in the presence of the dsDNA binding dye, and in another embodiment a melting curve is generated for the target nucleic acid by measuring fluorescence from the dsDNA binding dye as the mixture is heated. Dyes for use in nucleic acid analysis and methods for making dyes are also provided.

Claims (14)

1. A method of PCR analysis comprising the steps of:

providing a mixture of a dsDNA binding dye, at least one target nucleic acid, and primers configured for amplifying the target nucleic acid,

amplifying the target nucleic acid in the presence of the dsDNA binding dye,

monitoring fluorescence of the dsDNA binding dye,

generating a melting curve for the target nucleic acid,

normalizing magnitude differences of the melting curve,

repeating the providing, amplifying, generating and normalizing steps with at least one additional target nucleic acid, and

plotting a fluorescence difference between the magnitude-difference-normalized melting curves, wherein the magnitude-difference-normalized melting curve of one target nucleic acid is selected as a standard and is plotted as the standard across melting temperatures and the magnitude-difference-normalized melting curve for each additional target nucleic acid is plotted as a difference from the standard across the melting temperatures.

2. The method of claim 1 , wherein the dsDNA binding dye has a percent saturation of at least 50%.

3. The method of claim 1 , wherein the dsDNA binding dye has a percent saturation of at least 90%.

4. The method of claim 1 , further comprising the step of temperature shifting the melting curves by superimposing a portion of each curve.

5. The method of claim 1 wherein the target nucleic acid and each additional target nucleic acid each comprises a first melting domain and a second melting domain and the temperature shifting step comprises superimposing a portion of each curve representing the second melting domain.

6. The method of claim 1 , wherein the standard is plotted as zero across all temperatures and the difference between the standard and each melting curve for each additional target nucleic acid across temperatures is compared to the zeroed standard.

7. The method of claim 1 wherein the dye is selected from the group consisting of PO-PRO™-1, JO-PRO™-1, BO-PRO™-1, SYTO® 45, POPO™-3, SYTO® 12, TOTO™-3, SYTOX® Blue, YOYO®-3, SYTO® 43, SYTO® 11, G5, H5, D6, E6, P6, R6, Y6, Z6, and D8.

Assignments (2)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS (RECORDED 9/5/12 AT REEL/FRAME 028914/0592) Recorded Dec 11, 2014
From: ATHYRIUM OPPORTUNITIES FUND (A) LP, AS ADMINISTRATIVE AGENT
To: BIOFIRE DIAGNOSTICS, INC.
Reel/Frame 034609/0944 →
SECURITY AGREEMENT Recorded Sep 5, 2012
From: BIOFIRE DIAGNOSTICS, INC.
To: ATHYRIUM OPPORTUNITIES FUND (A) LP
Reel/Frame 028914/0592 →